MicroRNA-105 is involved in TNF-α-related tumor microenvironment enhanced colorectal cancer progression
MicroRNA-105 is involved in TNF-α-related tumor microenvironment enhanced colorectal cancer progression
复制标题
MicroRNA-105 参与 TNF-α 相关的肿瘤微环境,增强结直肠癌的进展。
DOI:
10.1038/s41419-017-0048-x
复制
发表时间:
2017-12-13
影响因子:
9
通讯作者:
Zhao, Liang
中科院分区:
文献类型:
--
作者:
Shen, Zetao;Zhou, Rui;Zhao, Liang
TNF-alpha is a central proinflammatory cytokine contributing to malignant tumor progression in tumor microenvironment. In this study, we found the upregulation of miR-105 in colorectal cancer was associated with aggressive phenotype, and the enhanced expression of miR-105 was required for TNF-alpha-induced epithelial-mesenchymal transition (EMT). The expression of miR-105 was remarkably stimulated by TNF-alpha in a time-dependent manner using real-time qPCR analysis. Inhibition of miR-105 remarkably weakened the aggressive effects of TNF-alpha through preventing the activation of NF-kappa B signaling and the initiation of EMT. Furthermore, miR-105 was demonstrated directly targeted on the 3'-UTRs of RAP2C, a Rap2 subfamily of small GTP-binding protein. Consistently, suppression of RAP2C stimulated the role of miR-105, which dramatically promoted the invasion and metastasis of CRC cells. Thalidomide, a TNF-alpha and NF-kappa B inhibitor, significantly weakened the metastasis and homing capacity of miR-105-overexpressed CRC cells in nude mice. Our investigation initiatively illustrated the modulatory role of miR-105 in TNF-alpha-induced EMT and further CRC metastasis. We also offer a better understanding of TNF alpha-induced metastasis and suggest an effective therapeutic strategy against CRC metastasis.